Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee

24Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Vaccine hesitancy is a global challenge. This has become even more visible during the COVID-19 pandemic. In most European countries with a sufficient vaccine supply, public programs failed to achieve coverage of more than 80%. There are various reasons for this phenomenon: in addition to political positions and religious beliefs, many would rather rely on opinions than facts. These opinions are nurtured by myths, repeated over social media and the internet. Vaccines preventing infections, disease, and cancer caused by human papillomavirus (HPV) have been available for more than 15 years. After clinical trials provided data from tens of thousands of study participants, we now have the experience and observational data from hundreds of millions of vaccine doses distributed worldwide.1 These vaccines have demonstrated that they prevent not only HPV infections and pre-invasive disease, but also invasive cervical cancer.2-4

Author supplied keywords

Cite

CITATION STYLE

APA

Taumberger, N., Joura, E. A., Arbyn, M., Kyrgiou, M., Sehouli, J., & Gultekin, M. (2022, July 12). Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee. International Journal of Gynecological Cancer. BMJ Publishing Group. https://doi.org/10.1136/ijgc-2022-003685

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free